5MPA.SG - Midatech Pharma Plc

Stuttgart - Stuttgart Delayed price. Currency in EUR

Midatech Pharma Plc

65 Innovation Drive
Milton Park
Abingdon OX14 4RQ
United Kingdom
44 1235 888 300

Full-time employees85

Key executives

NameTitlePayExercisedYear born
Mr. Nicholas John Robbins-CherryCFO, Company Sec. & Director298.24kN/A1969
Dr. Craig Richard CookCEO, COO & DirectorN/AN/A1967
Mr. Rob Rainey FCA MBA MAHead of Corp. Devel.N/AN/AN/A
Dr. Tim Sparey Ph.D.Chief Bus. OfficerN/AN/AN/A
Mr. Justin Barry BSc (Hons.), MBIOL, CBIOL, QPHead of ManufacturingN/AN/AN/A
Amounts are as of 31 December 2016, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.


Midatech Pharma PLC, a specialty pharmaceutical company, focuses on developing and commercializing products in oncology and immunotherapy in the United States and the United Kingdom. The company operates through two segments, Pipeline Research and Development; and Commercial. Its products include Zuplenz, an oral soluble film for moderately emetogenic chemotherapy-induced nausea and vomiting, radiotherapy-induced nausea and vomiting, and post-operative nausea and vomiting; Gelclair, an oral gel barrier device indicated for the management and relief of pain due to oral mucositis; Oravig, an orally dissolving buccal tablet for oral thrush; and Soltamox, an oral liquid solution of tamoxifen citrate, for the treatment and prevention of breast cancer. Midatech Pharma PLC is collaborating with universities and pharmaceutical companies to develop its platform technologies into a range of products. Midatech Pharma PLC was founded in 2000 and is headquartered in Abingdon, the United Kingdom.

Corporate governance

Midatech Pharma Plc’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.
By using Yahoo you agree that Yahoo and partners may use Cookies for personalisation and other purposes